Drug Research
Reviving Old Drugs with Specialty Intermediates in Europe
Drug development in the European pharmaceutical industry is undergoing a dramatic shift, largely due to the repurposing and reformulation of pre-existing chemicals rather than...
Drug Research
Specialty Chemicals Solubility Enhances Drug Formulations
The need to improve the effectiveness, safety, and accessibility of drugs drives research and innovation in the ever-evolving pharmaceutical industry. The problem of solubility...
Techno Trends
AI in Specialty Chemicals is Advancing Innovation
The pharmaceutical specialty chemical industry is in the process of a seismic upheaval, powered by the revolutionary potential of artificial intelligence (AI). With its...
Business & Industry
EU Green Regulations Impact Pharmaceutical Chemical Industry
Pharma specialty chemicals companies have been experiencing serious challenges based on the greening regulations enforced by the European Union. Such regulatory systems promote the...
Clinical Trials
FDA Approval of AMVUTTRA for ATTR Amyloidosis
Alnylam Pharmaceuticals, Inc., a global leader in RNAi therapeutics, has announced U.S. FDA approval of AMVUTTRA® (vutrisiran) for the treatment of cardiomyopathy associated with...
Clinical Trials
Rina-S Shows Promise in Advanced Ovarian Cancer
Genmab has reported encouraging findings from the Phase 2 RAINFOL-01 trial of rinatabart sesutecan (Rina-S®), an experimental folate receptor-alpha (FRα)-targeted, TOPO1 antibody-drug combination (ADC)....
News
Pharma Support Powers Sofinnova Biotech Acceleration Fund
Sofinnova Partners Closes €165M Biotech Acceleration Fund with Strong Pharma Support
European life sciences investment firm Sofinnova Partners has announced the final close of its...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read
